Ironwood Pharma (IRWD) Reports Q1 Lost Per Share of 24c

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.24), may note compare the analyst estimate of ($0.23). Revenue for the quarter came in at $28.9 million versus the consensus estimate of $32.3 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• Scotiabank Starts Affirm Holdings (AFRM) at Sector Outperform
• Adobe (ADBE) PT Raised to $315 at RBC Capital